Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Inflammatix logo

Inflammatix

Recent Finacing

Series E

Recent Raise

$57M

Inflammatix is a molecular diagnostics company developing rapid point-of-care tests that read a patient’s immune response to distinguish bacterial from viral infections.

California, United States
51-100
Private
inflammatix.com
PitchBook

Highlights

Focus Areas

Bioinformatics
Biotechnology
Health Care
Health Diagnostics

Recent Investors

Northpond Ventures logo
Khosla Ventures logo
Think.Health Ventures logo
D1 Capital Partners logo
OSF Ventures logo
Vesalius Biocapital logo
Raw Ventures logo
OSF Healthcare logo
Iberis Capital logo
G
Biomedical Advanced Research and Development Authority logo
National Institute of General Medical Sciences logo

Financials

$200.1M

Total Raised

5

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at Inflammatix.